Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024

Description

Thyroid Gland Disorder Treatment Market Growth & Trends:

The global thyroid gland disorder treatment market size is expected to reach USD 2.84 billion in 2030 and is projected to grow at a CAGR of 3.6% from 2024 to 2030. An increase in the prevalence of thyroid diseases around the globe is expected to drive demand for anti-thyroid drugs in the coming years. Hypothyroidism is one of the leading causes of hospitalization in U.S. Growing awareness about disease management amongst healthcare professionals and patients is another factor augmenting the market growth. There are various private and public organizations working toward spreading awareness related to disease management, such as the British Thyroid Foundation, The American Thyroid Association (ATA), and Thyroid Foundation of Canada.

Rising demand for these drugs has resulted in the development of various generic equivalents of branded drugs to treat thyroid gland disorders. Generic drug manufacturers are focusing on strategies such as new product development, distribution channel enhancement, regional expansions, and collaborations with other companies for marketing their products to gain an edge over the competition. In addition, regulatory authorities that approve generic versions of branded drugs are working to overcome delays in product approvals and enable the availability of these drugs at a lower price. This is expected to boost the market over the forecast period.

Thyroid Gland Disorder Treatment Market Report Highlights:

Hypothyroidism dominated the market and accounted for a market share of 68.7% in 2023 and is expected to maintain its position throughout the forecast period. On the other hand, hyperthyroidism is expected to witness steady growth on account of the increase in the incidence of Graves' disease
The oral route is the most preferred or most frequently used route of administration owing to its convenience and simplicity, which helps improve patient compliance. The market is driven by the presence of a strong pipeline of oral anti-thyroid medications
Wholesale distribution accounted for the largest market revenue share of 46.7% in 2023 owing to increasing spending on outpatient prescription drugs along with overall healthcare expenditure. E-commerce is expected to witness lucrative growth in the coming years
Asian countries, especially India and China, are expected to observe remarkable growth in the coming years
The market is fragmented in nature, with the presence of various large and small pharmaceutical players

Product Code: GVR-2-68038-118-4

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Thyroid Gland Disorder Treatment Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Thyroid Gland Disorder Treatment Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Thyroid Gland Disorder Treatment Market: Indication Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Thyroid Gland Disorder Treatment Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
4.3. Hypothyroidism
- 4.3.1. Hypothyroidism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Hyperthyroidism
- 4.4.1. Hyperthyroidism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Thyroid Gland Disorder Treatment Market: Drug Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Thyroid Gland Disorder Treatment Market: Drug Movement Analysis, 2023 & 2030 (USD Million)
5.3. Levothyroxine
- 5.3.1. Levothyroxine Thyroid Gland Disorder Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Liothyroxine
- 5.4.1. Liothyroxine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Propylthiouracil
- 5.5.1. Liothyroxine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Imidazole-based compounds
- 5.6.1. Imidazole-based compounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Thyroid Gland Disorder Treatment Market: Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Thyroid Gland Disorder Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Wholesale Distribution
- 6.3.1. Wholesale Distribution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Sales
- 6.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Online Pharmacy
- 6.5.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Thyroid Gland Disorder Treatment Market: Route of Administration Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Thyroid Gland Disorder Treatment Market: Route of Administration Movement Analysis, 2023 & 2030 (USD Million)
7.3. Oral
- 7.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Intravenous
- 7.4.1. Intravenous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Thyroid Gland Disorder Treatment Market: Regional Estimates & Trend Analysis

8.1. Thyroid Gland Disorder Treatment Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
- 8.2.1. North America Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Canada Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
  - 8.2.4.1. Mexico Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. UK Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
  - 8.3.3.1. Germany Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. France Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Italy Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Spain Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Denmark Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Sweden Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Sweden Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Japan Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. China
  - 8.4.3.1. China Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. India Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. South Korea
  - 8.4.5.1. South Korea Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Thailand
  - 8.4.6.1. Thailand Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
  - 8.5.3.1. Argentina Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. South Africa Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. Saudi Arabia Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait Thyroid Gland Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. Abbvie Inc.
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Amgen Inc.
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. GSK Plc
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. Merck KGaA
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Viatris Inc.
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Novartis AG
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Pfizer Inc.
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Takeda Pharmaceutical Company Limited
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Elexis Inc.
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. IBSA Pharma (IBSA Group)
  - 9.4.10.1. Participant's Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Recent Developments/ Strategic Initiatives

Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030